Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
ET.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.101EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FG.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.88EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCYEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used